Impact of diabetes on 1‐year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30090
Abstract: This sub‐study of the SORT OUT IX trial sought to compare clinical outcomes between patients with diabetes randomized to implantation of either the polymer‐free biolimus A9‐coated BioFreedom stent (BF‐BES) or the ultra‐thin strut, biodegradable polymer… read more here.
Keywords: patients diabetes; impact; sort trial; year ... See more keywords